Prognostic Impact of Chromosome Aberrations in Ovarian Cancer
Author Information
Author(s): T. Pejovic, A. Himmelmann, S. Heim, N. Mandahl, U.-M. Floderus, S. Furgyik, B. Elmfors, G. Helm, H. Willen, F. Mitelman
Primary Institution: University Hospital, Lund, Sweden
Hypothesis
Can cytogenetic analysis of tumor cells provide prognostic information in patients with malignant ovarian tumors?
Conclusion
Cytogenetic analysis of tumor cells may be clinically valuable in assessing prognosis in patients with malignant ovarian tumors.
Supporting Evidence
- Patients with abnormal karyotypes had shorter survival than those with normal karyotypes.
- Poorly differentiated tumors had the most complex karyotypes.
- Stage, grade, and residual tumor after primary surgery correlated with survival time.
Takeaway
Doctors looked at the chromosomes in ovarian cancer tumors to see if they could predict how long patients would live. They found that certain chromosome changes were linked to shorter survival.
Methodology
Cytogenetic analysis was performed on tumor samples from 88 previously untreated patients with primary malignant tumors of the ovary.
Limitations
The study had a relatively short follow-up time and a small number of patients.
Participant Demographics
The mean age of patients was 62.5 years, with a range from 24 to 87 years; 65 patients had good performance status, while 23 had poorer performance status.
Statistical Information
P-Value
P = 0.030
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website